AstraZeneca new tablet formulation of Calquence gets USFDA okay Ruchika Sharma8 Aug 2022 12:30 PM IST"The tablet can be taken with gastric acid-reducing agents, including proton pump inhibitors (PPIs), antacids and H2-receptor antagonists (H2RAs),"...
AstraZeneca Enhertu secures USFDA nod for HER2-low breast cancer Ruchika Sharma6 Aug 2022 2:30 PM ISTEnhertu is a HER2-directed ADC.
AstraZeneca- MSD gets EU nod for Lynparza to treat early-stage breast cancer Ruchika Sharma5 Aug 2022 5:23 PM ISTBreast cancer is the most diagnosed cancer worldwide with an estimated 2.3 million patients diagnosed in 2020.
AstraZeneca Covid jab Vaxzevria sales slide Ruchika Sharma1 Aug 2022 1:10 PM ISTThe group said annual revenue from Covid-19 medicines is anticipated to be broadly flat compared with 2021.
AstraZeneca India introduces Chronic Kidney Disease Academy Ruchika Sharma28 July 2022 1:45 PM ISTThe certificate training course on CKD latest updates will train about 1000 primary care physicians through three interactive modules.
CDSCO Panel nod to AstraZeneca Olaparib for BRCA Mutated HER2 Negative Breast Cancer Rahul Verma26 July 2022 5:48 PM ISTBased on the scientific data provided by the drug maker AstraZeneca, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
AstraZeneca Olaparib gets CDSCO Panel okay for BRCA mutated HER2 negative breast cancer Dr. Divya Colin23 July 2022 6:00 PM ISTNew Delhi: Based on the scientific data provided by the drug maker AstraZeneca, the Subject Expert Committee (SEC) functional under Central Drug...
AstraZeneca broadens haematological cancer pipeline with TeneoTwo acquisition Ruchika Sharma6 July 2022 12:30 PM ISTAstraZeneca will acquire all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m on deal closing.
Wuxi Biologics takes step to getting off US 'unverified' trade list Ruchika Sharma5 July 2022 10:00 AM ISTNew Delhi: Wuxi Biologics, a Chinese company that makes ingredients for AstraZeneca's COVID-19 vaccine, may be a step closer to being taken off a U.S....
Oxford Biomedica signs new deal to make AstraZeneca COVID vaccine Ruchika Sharma3 July 2022 12:00 PM ISTOxford: Oxford Biomedica plc, a gene and cell therapy group, has announced that it has signed a new three year Master Services & Development...
Herve Berdou appointed as Piramal Pharma Solutions new Chief Operating Officer Ruchika Sharma22 Jun 2022 11:41 AM ISTMumbai: Piramal Pharma Limited's Pharma Solutions business has announced the appointment of Herve Berdou as Chief Operating Officer, Piramal Pharma...
AstraZeneca, Ionis Pharma seek US nod for Eplontersen after positive trial data Ruchika Sharma21 Jun 2022 3:35 PM ISTThe data from the 35-week interim analysis will be presented at an upcoming medical meeting later this year.
